Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation

NCT02557997 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT02557997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02557997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Dolutegravir Based Regimen on HIV-1 Reservoir and Immune Activation
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2014
Completion date
September 30, 2016
Enrollment
202 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 infection